{"id":53211,"date":"2023-09-20T09:43:58","date_gmt":"2023-09-20T09:43:58","guid":{"rendered":"https:\/\/medsname.com\/cytomid\/"},"modified":"2026-04-30T10:25:12","modified_gmt":"2026-04-30T10:25:12","slug":"cytomid","status":"publish","type":"product","link":"https:\/\/medsbase.com\/el\/cytomid\/","title":{"rendered":"Cytomid"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Cytomid?<\/h3>\n<p style=\"margin:0;\"><strong>Cytomid<\/strong> is an oral tablet from Cipla containing <strong>flutamide 250 mg<\/strong> &mdash; a non-steroidal <strong>androgen-receptor antagonist (anti-androgen)<\/strong> \u03c7\u03c1\u03b7\u03c3\u03b9\u03bc\u03bf\u03c0\u03bf\u03b9\u03b5\u03af\u03c4\u03b1\u03b9 \u03b3\u03b9\u03b1 <strong>advanced or metastatic prostate cancer<\/strong>. Standard role: combined with an <strong>LHRH agonist<\/strong> (goserelin, leuprorelin) for combined androgen blockade (CAB). Standard dose: <strong>250 mg three times daily (8-hourly)<\/strong>. Main side effects: gynaecomastia and breast tenderness (common), hot flushes, hepatotoxicity (mandatory LFT monitoring), reduced libido, methaemoglobinaemia (rare). <strong>Mandatory: baseline + monthly LFTs for first 4 months, then periodic.<\/strong><\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>\u0391\u03c5\u03c4\u03cc \u03c0\u03bf\u03c5 \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03c4\u03b5 \u03bc\u03b5 \u03c4\u03b7\u03bd MedsBase:<\/strong> \u03a0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae\u03c2 WHO-GMP \u00b7 \u0394\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u00b7 \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae \u00b7 1,400+ \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 <a href=\"https:\/\/medsbase.com\/el\/reviews\/\">\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\"><strong>\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>&#9888; Specialist supervision required.<\/strong> Cancer medications must be prescribed by a treating oncologist with a confirmed diagnosis, baseline staging, and a defined treatment plan. Never start, stop, change dose, or use cancer medication outside of an oncology-led care plan. Most cancer drugs require regular blood-test monitoring (FBC, LFT, renal function), are absolutely contraindicated in pregnancy, and have significant drug interactions.<\/div>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 \u039a\u03c1\u03c5\u03c0\u03c4\u03bf\u03b3\u03c1\u03b1\u03c6\u03b7\u03bc\u03ad\u03bd\u03b7 \u039f\u03bb\u03bf\u03ba\u03bb\u03ae\u03c1\u03c9\u03c3\u03b7 \u0391\u03b3\u03bf\u03c1\u03ac\u03c2<\/strong> \u00b7 <strong>\ud83d\udcb3 \u0395\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03bf\u03c2 \u0395\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c2<\/strong> \u00b7 <strong>\ud83d\ude9a \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u0391\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae<\/strong> \u00b7 <strong>\u2b50 4.9\/5 \u03b1\u03c0\u03cc 1,400+ \u03c0\u03b5\u03bb\u03ac\u03c4\u03b5\u03c2<\/strong>\n<\/div>\n<h2 class=\"wp-block-heading\">What Is Cytomid?<\/h2>\n<p>Cytomid is an oral tablet from Cipla containing <strong>flutamide 250 mg<\/strong>. Flutamide is a non-steroidal anti-androgen that competitively blocks the androgen receptor in prostate cancer cells, inhibiting the proliferative effect of testosterone and dihydrotestosterone (DHT). It is used in <strong>advanced or metastatic prostate cancer<\/strong>, almost always combined with an LHRH agonist (goserelin, leuprorelin, triptorelin) for <strong>combined androgen blockade (CAB)<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\">How Does Cytomid Work?<\/h2>\n<p>Prostate cancer growth is driven by androgen-receptor signalling. Standard androgen deprivation therapy (ADT) suppresses ovarian androgen production through LHRH agonists. However, the adrenal glands continue to produce ~10% of total body androgens, and the residual signal is enough to drive disease progression in many patients. Cytomid blocks the androgen receptor itself, so the residual adrenal androgens cannot signal &mdash; producing more complete androgen blockade.<\/p>\n<ul>\n<li><strong>Competitive androgen-receptor antagonist<\/strong> &mdash; binds the AR and prevents testosterone \/ DHT from activating it.<\/li>\n<li><strong>Short half-life (~5 hours)<\/strong> &mdash; requires three-times-daily dosing.<\/li>\n<li><strong>Used to prevent &ldquo;tumour flare&rdquo;<\/strong> when starting LHRH agonist therapy &mdash; the initial LHRH-induced testosterone surge can transiently worsen disease, and pre-treatment with anti-androgen blocks this.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a7\u03c1\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/h2>\n<ul>\n<li><strong>Combined androgen blockade (CAB)<\/strong> in advanced or metastatic prostate cancer (with LHRH agonist)<\/li>\n<li><strong>Tumour flare prevention<\/strong> at LHRH agonist initiation (2&ndash;4 weeks pre-treatment)<\/li>\n<li><strong>After biochemical recurrence<\/strong> as part of intermittent or continuous androgen deprivation regimens<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cytomid Dosage and How to Take<\/h2>\n<p>\u03a4\u03c5\u03c0\u03b9\u03ba\u03ae \u03b4\u03cc\u03c3\u03b7: <strong>250 mg three times daily (8-hourly)<\/strong>.<\/p>\n<ol>\n<li><strong>Three times daily, 8 hours apart.<\/strong> Take with food to reduce GI upset.<\/li>\n<li><strong>\u039a\u03b1\u03c4\u03b1\u03c0\u03b9\u03b5\u03af\u03c4\u03b5 \u03bf\u03bb\u03cc\u03ba\u03bb\u03b7\u03c1\u03bf \u03bc\u03b5 \u03bd\u03b5\u03c1\u03cc.<\/strong><\/li>\n<li><strong>Mandatory monitoring:<\/strong> baseline LFTs (AST, ALT) and PSA. Repeat LFTs <strong>monthly for the first 4 months<\/strong>, then every 3&ndash;6 months. PSA every 3 months. Stop and investigate if AST\/ALT &gt; 3&times; upper limit of normal.<\/li>\n<li><strong>Pre-LHRH-agonist tumour-flare prevention:<\/strong> start Cytomid 2&ndash;4 weeks before LHRH agonist initiation, continue for at least 1 month after.<\/li>\n<li><strong>Do not stop without oncologist instruction.<\/strong><\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Side Effects of Cytomid<\/h2>\n<p><strong>\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2:<\/strong><\/p>\n<ul>\n<li>Gynaecomastia and breast tenderness (40&ndash;70% with monotherapy; less with CAB)<\/li>\n<li>Hot flushes<\/li>\n<li>Reduced libido and erectile dysfunction<\/li>\n<li>Fatigue, asthenia<\/li>\n<li>Diarrhoea (especially flutamide)<\/li>\n<li>\u0389\u03c0\u03b9\u03b1 \u03b3\u03b1\u03c3\u03c4\u03c1\u03b5\u03bd\u03c4\u03b5\u03c1\u03b9\u03ba\u03ae \u03b5\u03bd\u03cc\u03c7\u03bb\u03b7\u03c3\u03b7<\/li>\n<\/ul>\n<p><strong>Important &mdash; mandate monitoring:<\/strong><\/p>\n<ul>\n<li><strong>\u0397\u03c0\u03b1\u03c4\u03bf\u03c4\u03bf\u03be\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1<\/strong> &mdash; can be severe and unpredictable. Stop immediately for jaundice, dark urine, severe fatigue, or AST\/ALT &gt; 3&times; ULN. Most cases occur within first 4 months.<\/li>\n<li>Methaemoglobinaemia &mdash; cyanosis, headache, dyspnoea (flutamide-specific)<\/li>\n<li>Diarrhoea more common than with bicalutamide<\/li>\n<\/ul>\n<p><strong>\u03a3\u03c0\u03ac\u03bd\u03b9\u03b1:<\/strong> haemolytic anaemia, photosensitivity, severe skin reactions.<\/p>\n<h2 class=\"wp-block-heading\">\u03a0\u03c1\u03bf\u03b5\u03b9\u03b4\u03bf\u03c0\u03bf\u03b9\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03c1\u03bf\u03c6\u03c5\u03bb\u03ac\u03be\u03b5\u03b9\u03c2<\/h2>\n<ul>\n<li><strong>\u0395\u03b3\u03ba\u03c5\u03bc\u03bf\u03c3\u03cd\u03bd\u03b7 \u03ba\u03b1\u03b9 \u03b8\u03b7\u03bb\u03b1\u03c3\u03bc\u03cc\u03c2:<\/strong> not applicable (male-only indication) but anti-androgens are fetotoxic if taken in error during pregnancy.<\/li>\n<li><strong>\u039b\u03b5\u03b9\u03c4\u03bf\u03c5\u03c1\u03b3\u03af\u03b1 \u03ae\u03c0\u03b1\u03c4\u03bf\u03c2:<\/strong> mandatory monthly LFTs for first 4 months. Stop for AST\/ALT &gt; 3&times; ULN.<\/li>\n<li><strong>Diabetes:<\/strong> may worsen glycaemic control.<\/li>\n<li><strong>\u039a\u03b1\u03c1\u03b4\u03b9\u03b1\u03b3\u03b3\u03b5\u03b9\u03b1\u03ba\u03ac:<\/strong> ADT in general is associated with increased cardiovascular events. Optimise modifiable risk factors.<\/li>\n<li><strong>Gynaecomastia prophylaxis:<\/strong> low-dose tamoxifen 10&ndash;20 mg\/day or prophylactic breast radiotherapy reduces incidence (specialist).<\/li>\n<li><strong>Driving:<\/strong> caution &mdash; fatigue and dizziness may impair driving.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u0391\u03bb\u03bb\u03b7\u03bb\u03b5\u03c0\u03b9\u03b4\u03c1\u03ac\u03c3\u03b5\u03b9\u03c2 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;\">\u03a3\u03c5\u03bd\u03b4\u03c5\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03bc\u03b5<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">\u0391\u03c0\u03bf\u03c4\u03ad\u03bb\u03b5\u03c3\u03bc\u03b1<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">\u03a4\u03b9 \u03bd\u03b1 \u03ba\u03ac\u03bd\u03b5\u03c4\u03b5<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Warfarin and other coumarin anticoagulants<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Significant INR increase &mdash; bleeding risk<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Check INR weekly initially. Reduce warfarin dose by 30&ndash;50%.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">CYP3A4 inhibitors (major effect)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Raise flutamide levels<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor for hepatotoxicity.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">LHRH agonists (goserelin, leuprorelin)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Standard combination &mdash; combined androgen blockade<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Standard CAB regimen.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u0391\u03bb\u03ba\u03bf\u03cc\u03bb<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u03a0\u03c1\u03bf\u03c3\u03b8\u03b5\u03c4\u03b9\u03ba\u03ae \u03b7\u03c0\u03b1\u03c4\u03bf\u03c4\u03bf\u03be\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Limit alcohol intake during treatment.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n<ul>\n<li>Store at room temperature, 15&ndash;25&deg;C, in original blister.<\/li>\n<li>Keep out of reach of children, women, and pets &mdash; anti-androgens are fetotoxic.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ad\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2 \u039b\u03cd\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c4\u03bf MedsBase<\/h2>\n<p>Other oncology medications stocked alongside this product:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/bdenza\/\"><strong>Bdenza (enzalutamide 40 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/bicalumutide\/\"><strong>Bicalumutide (bicalutamide 50 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/medsbase.com\/el\/anti-cancer-medication\/\">Browse all anti-cancer medications &rarr;<\/a><\/p>\n<h2 id=\"faqs\">\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n<h3 class=\"wp-block-heading\">Why is Cytomid usually combined with an LHRH agonist?<\/h3>\n<p>LHRH agonists (goserelin, leuprorelin) suppress testicular androgen production, but the adrenal glands continue producing ~10% of body androgens that can drive prostate cancer growth. Cytomid blocks the androgen receptor itself, so adrenal androgens cannot signal. The combination is called <strong>combined androgen blockade (CAB)<\/strong> and produces deeper androgen suppression than LHRH agonist alone in advanced disease.<\/p>\n<h3 class=\"wp-block-heading\">What is &ldquo;tumour flare&rdquo; and why does Cytomid prevent it?<\/h3>\n<p>When LHRH agonist therapy starts, the pituitary is initially stimulated and testosterone surges for 1&ndash;2 weeks before downregulation kicks in. In patients with significant disease burden (bone metastases, urinary obstruction, spinal cord compression risk), this transient testosterone surge can worsen symptoms acutely. Starting Cytomid 2&ndash;4 weeks before the LHRH agonist blocks the receptor and prevents the flare.<\/p>\n<h3 class=\"wp-block-heading\">How is gynaecomastia managed?<\/h3>\n<p>Breast tenderness and gynaecomastia affect 40&ndash;70% of patients on bicalutamide monotherapy at higher doses. Prophylaxis options: <strong>low-dose tamoxifen 10&ndash;20 mg\/day<\/strong> (most evidence) or <strong>prophylactic breast radiotherapy<\/strong> as a single 8&ndash;12 Gy fraction before starting anti-androgen therapy. Discuss with the oncologist before starting if cosmetic concerns are significant.<\/p>\n<h3 class=\"wp-block-heading\">What blood tests do I need?<\/h3>\n<p><strong>Mandatory:<\/strong> baseline LFTs (AST, ALT) and PSA. Then LFTs <strong>monthly for the first 4 months<\/strong>, then every 3&ndash;6 months. PSA every 3 months. Stop Cytomid immediately and contact your oncologist if AST\/ALT &gt; 3&times; ULN, or for any jaundice, dark urine or severe fatigue.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol on Cytomid?<\/h3>\n<p>Limit alcohol &mdash; both alcohol and flutamide are hepatotoxic and the combination amplifies the risk of severe drug-induced liver injury. Occasional small amounts are usually tolerable; heavy or daily drinking should be avoided throughout treatment.<\/p>\n<h3 class=\"wp-block-heading\">Why is Cytomid three times daily instead of once daily?<\/h3>\n<p>Flutamide has a short half-life (~5 hours) compared with bicalutamide (~6 days), so it requires three-times-daily dosing for stable androgen-receptor blockade. Bicalutamide&#39;s once-daily convenience is one reason it has largely replaced flutamide in modern practice.<\/p>\n<h3 class=\"wp-block-heading\">Will Cytomid affect my heart?<\/h3>\n<p>Anti-androgen monotherapy has minimal direct cardiovascular effect, but the broader androgen deprivation therapy (LHRH agonist + anti-androgen) is associated with increased cardiovascular events including MI and stroke. Optimise cardiovascular risk factors: BP control, statin if hyperlipidaemic, smoking cessation, exercise, weight management.<\/p>\n<h3 class=\"wp-block-heading\">Can I stop Cytomid if PSA stays low?<\/h3>\n<p>Discuss with your oncologist. In some intermittent-CAB protocols, CAB is held when PSA is suppressed below threshold and resumed when PSA rises &mdash; this can reduce side effects without compromising survival. Never stop unilaterally &mdash; PSA monitoring and timing of restart are critical.<\/p>\n<p><!-- medsbase-why-order --><\/p>\n<h3>\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n<p>\u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03c4\u03af\u03b4\u03b1 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ad\u03bd\u03b1 <strong>\u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf \u03b1\u03c0\u03cc \u03c4\u03b7 WHO-GMP \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae<\/strong>. \u039f\u03b9 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b5\u03c2 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03b1\u03c0\u03bb\u03ac, \u03b1\u03c3\u03ae\u03bc\u03b1\u03bd\u03c4\u03b1 \u03c0\u03b1\u03ba\u03ad\u03c4\u03b1 \u03b1\u03c0\u03cc \u03c4\u03bf\u03c5\u03c2 \u03c3\u03c5\u03bd\u03b5\u03c1\u03b3\u03ac\u03c4\u03b5\u03c2 \u03bc\u03b1\u03c2 \u03c3\u03c4\u03b7\u03bd \u03b5\u03ba\u03c0\u03bb\u03ae\u03c1\u03c9\u03c3\u03b7 \u03ba\u03b1\u03b9 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"\/el\/medsbase-re-shipment-assurance-policy\/\">\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/a>: \u03b5\u03ac\u03bd \u03ad\u03bd\u03b1 \u03b4\u03ad\u03bc\u03b1 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c3\u03c4\u03ad\u03bb\u03bd\u03bf\u03c5\u03bc\u03b5 \u03bc\u03b9\u03b1 \u03b4\u03c9\u03c1\u03b5\u03ac\u03bd \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae, \u03c7\u03c9\u03c1\u03af\u03c2 \u03b5\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Related Anti-Cancer Medications<\/h3>\n<p>Other oncology medications stocked alongside this product:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/bicalumutide\/\">Bicalumutide (bicalutamide 50 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/bdenza\/\">Bdenza (enzalutamide 40 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/endace\/\">Endace (megestrol 40\/160 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/tamilong\/\">Tamilong (tamoxifen 10\/20 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/xtane\/\">Xtane (exemestane 25 mg)<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Treats prostate cancer<br \/>\n\u2705 Reduces testosterone levels<br \/>\n\u2705 Slows cancer growth<br \/>\n\u2705 Manages hormonal imbalances<br \/>\n\u2705 Lowers high blood pressure<\/p>","protected":false},"featured_media":53212,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223],"product_tag":[],"class_list":{"0":"post-53211","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/53211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=53211"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/53212"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=53211"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=53211"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=53211"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=53211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}